BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Marchegiani G, Mino-Kenudson M, Sahora K, Morales-Oyarvide V, Thayer S, Ferrone C, Warshaw AL, Lillemoe KD, Fernández-Del Castillo C. IPMN involving the main pancreatic duct: biology, epidemiology, and long-term outcomes following resection. Ann Surg 2015;261:976-83. [PMID: 24979607 DOI: 10.1097/SLA.0000000000000813] [Cited by in Crossref: 70] [Cited by in F6Publishing: 23] [Article Influence: 10.0] [Reference Citation Analysis]
Number Citing Articles
1 Crippa S, Belfiori G, Tamburrino D, Partelli S, Falconi M. Indications to total pancreatectomy for positive neck margin after partial pancreatectomy: a review of a slippery ground. Updates Surg 2021;73:1219-29. [PMID: 34331677 DOI: 10.1007/s13304-021-01141-0] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Jana T, Shroff J, Bhutani MS. Pancreatic cystic neoplasms: Review of current knowledge, diagnostic challenges, and management options. J Carcinog. 2015;14:3. [PMID: 25821410 DOI: 10.4103/1477-3163.153285] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
3 Zhuge X, Zhou H, Chen L, Chen H, Chen X, Guo C. The association between serum ferritin levels and malignant intraductal papillary mucinous neoplasms. BMC Cancer 2021;21:1253. [PMID: 34800987 DOI: 10.1186/s12885-021-08986-z] [Reference Citation Analysis]
4 Al Efishat M, Allen PJ. Therapeutic Approach to Cystic Neoplasms of the Pancreas. Surg Oncol Clin N Am 2016;25:351-61. [PMID: 27013369 DOI: 10.1016/j.soc.2015.11.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
5 Giuffrida P, Biagiola D, Ardiles V, Uad P, Palavecino M, de Santibañes M, Clariá RS, Pekolj J, de Santibañes E, Mazza O. Long-term follow-up of Branch-Duct Intraductal Papillary Mucinous Neoplasms with negative Sendai Criteria: the therapeutic challenge of patients who convert to positive Sendai Criteria. HPB (Oxford) 2021;23:290-300. [PMID: 32709558 DOI: 10.1016/j.hpb.2020.06.011] [Reference Citation Analysis]
6 Larson A, Kwon RS. Natural History of Pancreatic Cysts. Dig Dis Sci 2017;62:1770-7. [PMID: 28315034 DOI: 10.1007/s10620-017-4542-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
7 Pulvirenti A, Marchegiani G, Malleo G, Borin A, Allegrini V, Bassi C, Salvia R. Cystic Neoplasm of the Pancreas. Indian J Surg 2015;77:387-92. [PMID: 26722201 DOI: 10.1007/s12262-015-1363-z] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
8 Li Y, Zhu Z, Peng L, Jin Z, Sun L, Song B. The pathological features and prognoses of intraductal papillary mucinous neoplasm and mucinous cystic neoplasm after surgical resection: a single institution series. World J Surg Oncol. 2020;18:287. [PMID: 33148260 DOI: 10.1186/s12957-020-02063-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Ahmad M, Maegawa FB, Ashouri Y, Le E, Mendoza Ladd A, Elhanafi S, Philipovskiy A, Tyroch AH, Konstantinidis IT. Facility Type Affects Treatment Outcomes for Patients With Mucinous Cystic Neoplasms and Intraductal Papillary Mucinous Neoplasms of the Pancreas. Pancreas 2021;50:1422-6. [PMID: 35041342 DOI: 10.1097/MPA.0000000000001948] [Reference Citation Analysis]
10 Gerry JM, Poultsides GA. Surgical Management of Pancreatic Cysts: A Shifting Paradigm Toward Selective Resection. Dig Dis Sci. 2017;62:1816-1826. [PMID: 28421458 DOI: 10.1007/s10620-017-4570-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
11 Esposito I, Häberle L, Yavas A, Kraft A, Gaida MM. [Intraductal neoplasms of the pancreas]. Pathologe 2021;42:472-83. [PMID: 34402978 DOI: 10.1007/s00292-021-00966-1] [Reference Citation Analysis]
12 Djordjevic V, Grubor N, Kovac JD, Micev M, Milic N, Knezevic D, Gregoric P, Lausevic Z, Kerkez M, Knezevic S, Radenkovic D. Comparison of Preoperative Evaluation with the Pathological Report in Intraductal Papillary Mucinous Neoplasms: A Single-Center Experience. J Clin Med 2021;10:678. [PMID: 33578680 DOI: 10.3390/jcm10040678] [Reference Citation Analysis]
13 Scholten L, Latenstein AE, Aalfs CM, Bruno MJ, Busch OR, Bonsing BA, Koerkamp BG, Molenaar IQ, Ubbink DT, van Hooft JE, Fockens P, Glas J, DeVries JH, Besselink MG; Dutch Pancreatic Cancer Group. Prophylactic total pancreatectomy in individuals at high risk of pancreatic ductal adenocarcinoma (PROPAN): systematic review and shared decision-making programme using decision tables. United European Gastroenterol J 2020;8:865-77. [PMID: 32703081 DOI: 10.1177/2050640620945534] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
14 Hipp J, Mohamed S, Pott J, Sick O, Makowiec F, Hopt UT, Fichtner-Feigl S, Wittel UA. Management and outcomes of intraductal papillary mucinous neoplasms. BJS Open 2019;3:490-9. [PMID: 31388641 DOI: 10.1002/bjs5.50156] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
15 Laquière A, Lagarde A, Napoléon B, Bourdariat R, Atkinson A, Donatelli G, Pol B, Lecomte L, Curel L, Urena-Campos R, Helbert T, Valantin V, Mithieux F, Buono JP, Grandval P, Olschwang S. Genomic profile concordance between pancreatic cyst fluid and neoplastic tissue. World J Gastroenterol 2019; 25(36): 5530-5542 [PMID: 31576098 DOI: 10.3748/wjg.v25.i36.5530] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Ren D, Li D, Jin X, Meng Z, Wu H. Intra-Ampullary Papillary-Tubular Neoplasm: A Population-Based Analysis. Med Sci Monit 2019;25:7332-41. [PMID: 31564715 DOI: 10.12659/MSM.916411] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
17 Al Efishat MA, Attiyeh MA, Eaton AA, Gönen M, Prosser D, Lokshin AE, Castillo CF, Lillemoe KD, Ferrone CR, Pergolini I, Mino-Kenudson M, Rezaee N, Dal Molin M, Weiss MJ, Cameron JL, Hruban RH, D'Angelica MI, Kingham TP, DeMatteo RP, Jarnagin WR, Wolfgang CL, Allen PJ. Multi-institutional Validation Study of Pancreatic Cyst Fluid Protein Analysis for Prediction of High-risk Intraductal Papillary Mucinous Neoplasms of the Pancreas. Ann Surg 2018;268:340-7. [PMID: 28700444 DOI: 10.1097/SLA.0000000000002421] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
18 Lazzarin G, Romano L, Coletti G, Di Sibio A, Vicentini V, Fatayer MWA, Schietroma M, Pessia B, Leone M, Carlei F, Giuliani A. Branch Duct - IPMN and PanIN, in IgG4-Autoimmune pancreatitis: A case report. Clin Case Rep 2020;8:2111-5. [PMID: 33235738 DOI: 10.1002/ccr3.2641] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Pflüger MJ, Felsenstein M, Schmocker R, Wood LD, Hruban R, Fujikura K, Rozich N, van Oosten F, Weiss M, Burns W, Yu J, Cameron J, Pratschke J, Wolfgang CL, He J, Burkhart RA. Gastric cancer following pancreaticoduodenectomy: Experience from a high-volume center and review of existing literature. Surg Open Sci 2020;2:32-40. [PMID: 32954246 DOI: 10.1016/j.sopen.2020.06.003] [Reference Citation Analysis]
20 Felix K, Honda K, Nagashima K, Kashiro A, Takeuchi K, Kobayashi T, Hinterkopf S, Gaida MM, Dang H, Brindl N, Kaiser J, Büchler MW, Strobel O. Noninvasive risk stratification of intraductal papillary mucinous neoplasia with malignant potential by serum apolipoprotein-A2-isoforms. Int J Cancer 2021. [PMID: 34778955 DOI: 10.1002/ijc.33875] [Reference Citation Analysis]
21 Marsoner K, Haybaeck J, Csengeri D, Waha JE, Schagerl J, Langeder R, Mischinger HJ, Kornprat P. Pancreatic resection for intraductal papillary mucinous neoplasm- a thirteen-year single center experience. BMC Cancer 2016;16:844. [PMID: 27809876 DOI: 10.1186/s12885-016-2887-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
22 Weissman S, Thaker R, Zeffren N, Sarfaraz R, Dedousis J. Intraductal Papillary Mucinous Neoplasm of the Pancreas: Understanding the Basics and Beyond. Cureus 2019;11:e3867. [PMID: 30899618 DOI: 10.7759/cureus.3867] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
23 Roth S, Zamzow K, Gaida MM, Heikenwälder M, Tjaden C, Hinz U, Bose P, Michalski CW, Hackert T. Evolution of the immune landscape during progression of pancreatic intraductal papillary mucinous neoplasms to invasive cancer. EBioMedicine 2020;54:102714. [PMID: 32259711 DOI: 10.1016/j.ebiom.2020.102714] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
24 Adsay V, Mino-Kenudson M, Furukawa T, Basturk O, Zamboni G, Marchegiani G, Bassi C, Salvia R, Malleo G, Paiella S, Wolfgang CL, Matthaei H, Offerhaus GJ, Adham M, Bruno MJ, Reid MD, Krasinskas A, Klöppel G, Ohike N, Tajiri T, Jang KT, Roa JC, Allen P, Fernández-del Castillo C, Jang JY, Klimstra DS, Hruban RH; Members of Verona Consensus Meeting, 2013. Pathologic Evaluation and Reporting of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Other Tumoral Intraepithelial Neoplasms of Pancreatobiliary Tract: Recommendations of Verona Consensus Meeting. Ann Surg 2016;263:162-77. [PMID: 25775066 DOI: 10.1097/SLA.0000000000001173] [Cited by in Crossref: 139] [Cited by in F6Publishing: 48] [Article Influence: 23.2] [Reference Citation Analysis]
25 Crippa S, Arcidiacono PG, De Cobelli F, Falconi M. Review of the diagnosis and management of intraductal papillary mucinous neoplasms. United European Gastroenterol J 2020;8:249-55. [PMID: 32213017 DOI: 10.1177/2050640619894767] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
26 Crippa S, Pezzilli R, Bissolati M, Capurso G, Romano L, Brunori MP, Calculli L, Tamburrino D, Piccioli A, Ruffo G, Fave GD, Falconi M. Active Surveillance Beyond 5 Years Is Required for Presumed Branch-Duct Intraductal Papillary Mucinous Neoplasms Undergoing Non-Operative Management. Am J Gastroenterol 2017;112:1153-61. [PMID: 28244498 DOI: 10.1038/ajg.2017.43] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 7.6] [Reference Citation Analysis]
27 Søreide K, Marchegiani G. Clinical Management of Pancreatic Premalignant Lesions. Gastroenterology 2021:S0016-5085(21)03649-0. [PMID: 34678216 DOI: 10.1053/j.gastro.2021.09.073] [Reference Citation Analysis]
28 Morales-Oyarvide V, Fong ZV, Fernández-Del Castillo C, Warshaw AL. Intraductal Papillary Mucinous Neoplasms of the Pancreas: Strategic Considerations. Visc Med 2017;33:466-76. [PMID: 29344522 DOI: 10.1159/000485014] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
29 Assarzadegan N, Thompson E, Salimian K, Gaida MM, Brosens LAA, Wood L, Ali SZ, Hruban RH. Pathology of intraductal papillary mucinous neoplasms. Langenbecks Arch Surg 2021. [PMID: 34047827 DOI: 10.1007/s00423-021-02201-0] [Reference Citation Analysis]
30 Harrington KA, Williams TL, Lawrence SA, Chakraborty J, Al Efishat MA, Attiyeh MA, Askan G, Chou Y, Pulvirenti A, McIntyre CA, Gonen M, Basturk O, Balachandran VP, Kingham TP, D'Angelica MI, Jarnagin WR, Drebin JA, Do RK, Allen PJ, Simpson AL. Multimodal radiomics and cyst fluid inflammatory markers model to predict preoperative risk in intraductal papillary mucinous neoplasms. J Med Imaging (Bellingham) 2020;7:031507. [PMID: 32613028 DOI: 10.1117/1.JMI.7.3.031507] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]